Expression of Notch1 in Ameloblastoma and Correlation with CBCT Imaging Subtypes

Authors

  • Baoyinbatu Gabiyatu Department of Health Research, Graduate School of Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Wenchao Li Department of Oral Implantology, Affiliated Hospital of Chifeng University, Inner Mongolia Key Laboratory of Oral Craniomaxillofacial Diseases Research, Chifeng 024000, Inner Mongolia, China
  • Wurihan Department of Surgery, Affiliated Hospital of Chifeng University, Chi Feng 024000, Inner Mongolia, China
  • Yuan Tian Department of Oral Implantology, Affiliated Hospital of Chifeng University, Inner Mongolia Key Laboratory of Oral Craniomaxillofacial Diseases Research, Chifeng 024000, Inner Mongolia, China
  • Lkhagvasuren Baasandorj Department of Health Research, Graduate School of Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Senhao Li Department of Oral Implantology, Affiliated Hospital of Chifeng University, Inner Mongolia Key Laboratory of Oral Craniomaxillofacial Diseases Research, Chifeng 024000, Inner Mongolia, China
  • Sarnai Tsagaankhuu Department of Oral Implantology, Affiliated Hospital of Chifeng University, Inner Mongolia Key Laboratory of Oral Craniomaxillofacial Diseases Research, Chifeng 024000, Inner Mongolia, China https://orcid.org/0000-0003-3427-5208
  • Damdindorj Boldbaatar Department of Physiology, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.24079/CAJMS.2023.12.004

Keywords:

Receptor, Notch1, Immunohistochemistry, Ameloblastoma, Cone-Beam Computed Tomography

Abstract

Objective: Ameloblastoma (AM) is a prevalent benign odontogenic tumor affecting the jaw bone. Its potential for recurrence and malignant transformation is closely associated with the regulation of signaling pathways. The objective of this study was to examine the expression and clinical significance of Notch1 in AM, along with exploring the correlation between Notch1 expression and AM imaging patterns.
Methods: The streptavidin-peroxidase (S-P) immunohistochemical technique was employed to detect the expression of Notch1 protein in the oral mucosa of 70 AM patients and 25 normal controls. Additionally, the preoperative cone-beam computed tomography (CBCT) images of the patients were classified, and the results were analyzed in relation to the expression of Notch1 protein in AM.
Results: The positive expression rate of Notch1 in the 70 AM patients was 74.29% (52/70), while the Notch1 expression rate in 26 oral mucosa patients was 19.23% (5/26), indicating a statistically significant difference (P < 0.05). The expression rate of Notch1 was 58.06% in single-room AM and lower in multi-room AM (85.29%) and honeycomb AM (100%) (P < 0.01). However, there was no significant difference in the expression rate of Notch1 between multi-room AM and honeycomb AM (P > 0.05).
Conclusion: Notch1 may serve as an important diagnostic indicator in AM, and the apoptosis inhibition ability and cell proliferation ability of single-room AM are lower compared to those of the room and honeycomb types

Downloads

Download data is not yet available.
Abstract
78
PDF
109

Author Biography

Baoyinbatu Gabiyatu, Department of Health Research, Graduate School of Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

Department of Surgery, Affiliated Hospital of Chifeng University, Chi Feng 024000, Inner Mongolia, China

Downloads

Published

2023-11-25

How to Cite

Gabiyatu, B., Li, W., Wurihan, Tian, Y., Baasandorj, L., Li, S., Tsagaankhuu, S., & Boldbaatar, D. (2023). Expression of Notch1 in Ameloblastoma and Correlation with CBCT Imaging Subtypes. Central Asian Journal of Medical Sciences, 9(4), 182–188. https://doi.org/10.24079/CAJMS.2023.12.004

Issue

Vol. 9 No. 4 (2023)

Section

Articles

License

Copyright (c) 2023 Mongolian National University of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.